Shares of the company are trading at $48.75 slightly over $44.67, the 50 day moving average and which is a tad above the 200 day moving average of $41.57. The 50 day moving average moved up $4.08 and the 200 day average moved up $7.18. (NASDAQ:ACHC) shares saw heavy trading volume with 1,093K shares changing hands by the end of trading on Thursday. Overall, volume was up 43.66% over the stocks normal daily volume.
Traders are feeling more bearish of late as inferred by the motion in short interest. The stock recorded a rise in short interest of 0.23% as of the latest report on May 31, 2017. Short interest grew from 25,169,112 to 25,226,660 over that period. With short interest at 25,226,660 and short average daily volume at 952,446, days to cover is 26.5 and the percentage of shorted shares is 0.29% as of May 31.
There has been some selling insider activity on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) recently. Director William Grieco disclosed the sale of 2,000 shares of ACHC stock. The shares were purchased at an average price of $45.42. Grieco now owns $2,089,910 of the stock per the Form 4 SEC filing. Reeve B. Waud, Director sold $2,254,500 worth of shares at an average price of $45.09 on Fri the 9th. Waud now owns $191,469,049 of stock per an SEC filing yesterday.
Ronald Morgan Fincher, Chief Operating Officer disclosed the sale of 86,483 shares of (ACHC). The shares were sold on May 1st for a price of $44.45. The Chief Operating Officer now owns $1,828,451 of the stock according to the SEC filing.
Here are some other firms who have updated their holdings. Creative Planning bolstered its ownership by buying 75 shares an increase of 4.8% as of 06/30/2017. Creative Planning currently owns 1,652 shares valued at $82,000. The value of the position overall is up by 18.8%. As of quarter end Gw&k Investment Management, LLC had bought a total of 140,422 shares growing its position 47.1%. The value of the investment in ACHC went from $12,997,000 to $21,654,000 increasing 66.6% since the last quarter.
Bank Of Montreal /can/ downsized its position by selling 2,001 shares a decrease of 3.9% in the quarter. Bank Of Montreal /can/ controls 49,653 shares with a value of $2,452,000. The total value of its holdings increased 8.9%. As of the end of the quarter Baird Financial Group, Inc. had disposed of 9,220 shares trimming its stake by 1.2%. The value of the investment in Acadia Healthcare Company, Inc. increased from $25,254,000 to $32,864,000 a change of $7,610,000 for the reporting period.
On February 17 Avondale Partners kept the company rating at “Market Outperform” but lowered the price target to $71.00 from $90.00. On February 1 analysts at KeyBanc starting coverage on ACHC with a rating of “Overweight” and price target of $85.00.
On September 16, 2015 JP Morgan issued its first research report on the stock setting a rating of “Neutral”. Leerink Swann added the stock to its research portfolio giving it an initial rating of “Outperform” and a price target of $90.00.
Equity analyst Mizuho Securities began coverage of the stock with an initial rating of “Buy” and projecting a price target of $84.00. May 21 investment analysts at Susquehanna left the company rating at “Positive” but moved up the price target from $75.00 to $83.00.
The company is down by -0.51% since yesterday’s close of $49. Acadia Healthcare Company, Inc.’s P/E ratio is 283.43 and market cap is 4.28B. In the last earnings report the EPS was $0.17 and is estimated to be $2.45 for the current year with 87,817,000 shares now outstanding. Next quarter’s EPS is forecasted at $0.66 and the next full year EPS is anticipated to be $2.82.
Acadia Healthcare Company, Inc., launched on October 24, 2005, is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is involved in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico..